Inactive Instrument

News BioHemp International, Inc. Other OTC

Equities

BKIT

US09076B1052

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

BioHemp International Provides Update on Current Status and its CBD Business Model	19-10-24	GL
BioHemp International, Inc. (OTC: BKIT) Acts in Response to SEC and OTC Trading Suspension	19-08-09	GL
Biohemp International, Inc. Reports Earnings Results for the Third Quarter Ended May 31, 2019	19-07-15	CI
BioHemp International (OTC: BKIT) Clarifies Recent 8-K - No Material Change in Share Structure	19-07-15	GL
Biohemp International, Inc. Enters Agreement with American Premium Water Corporation to White Label Cannabidiol Infused Water Utilizing HIPH’s Proprietary Hydro Nano Technology	19-07-11	CI
Daniel Blum, CEO at BioHemp International (OTC: BKIT), discusses new position, CBD opportunities, and long-term company goals with Cannabis Hemp Wire	19-07-10	GL
BioHemp International, Inc. (OTC: BKIT) Announces Deal to Private Label Water From American Premium Water Corporation (OTC: HIPH)	19-07-08	GL
Ludlow Research Initiates Coverage on BioHemp International (BKIT) Based on CBD Distribution Business Model And Assigns A Short Term 'Speculative' Price Target Per Share of $2.50 -$3.50	19-07-02	GL
CBD from Walmart to Kroger: Bigger Distribution Deals In Preparation For A Global CBD Market	19-06-25	NE
BioHemp International, Inc. Appoints Ryan Fishoff as Lead Advisor to the Company	19-06-24	CI
Blake Insomnia Therapeutics, Inc. has Changed its Name to BioHemp International, Inc	19-06-18	CI
Blake Insomnia Therapeutics, Inc. Announces Management Changes	19-05-17	CI
Blake Insomnia Therapeutics, Inc. Reports Earnings Results for the Second Quarter Ended February 28, 2019	19-04-23	CI
Blake Insomnia Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended November 30, 2018	19-02-27	CI
Blake Insomnia Therapeutics, Inc. will Change its Ticker to BKIT from BKITD	18-11-26	CI
Blake Insomnia Therapeutics, Inc. Announces Management Changes	18-03-12	CI
Blake Insomnia Therapeutics, Inc. announced that it expects to receive $1 million in funding	17-09-05	CI
Blake Insomnia Therapeutics Inc. Announces Submitting Clinical Trial Application for Phase II Clinical Testing to Health Canada	17-08-25	CI
Blake Insomnia Therapeutics Appoints Morten Albrechtsen to its Board of Directors	17-06-16	CI
Blake Insomnia Therapeutics Inc. Announces Board Appointments	17-05-25	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News BioHemp International, Inc. Other OTC

Equities

BKIT

US09076B1052

Summary

Filters